Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Other financing activities (2023 - 2026)

CG Oncology filings provide 3 years of Other financing activities readings, the most recent being $593000.0 for Q4 2025.

  • On a quarterly basis, Other financing activities fell 91.34% to $593000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $316000.0, a 90.77% decrease, with the full-year FY2025 number at $316000.0, down 90.77% from a year prior.
  • Other financing activities hit $593000.0 in Q4 2025 for CG Oncology, up from $270000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $6.8 million in Q4 2024 to a low of -$3.4 million in Q1 2024.
  • Median Other financing activities over the past 3 years was $116500.0 (2024), compared with a mean of $928875.0.
  • The widest YoY moves for Other financing activities: up 93.15% in 2025, down 751.35% in 2025.
  • CG Oncology's Other financing activities stood at $3.7 million in 2023, then skyrocketed by 85.53% to $6.8 million in 2024, then plummeted by 91.34% to $593000.0 in 2025.
  • The last three reported values for Other financing activities were $593000.0 (Q4 2025), $270000.0 (Q3 2025), and -$315000.0 (Q2 2025) per Business Quant data.